Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Achilleas
Achilleas Bouriazos, Peireas GR
| Patent application number | Description | Published |
|---|---|---|
| 20100022664 | Process for the partial hydrogenation of fatty acid esters - Suggested is a process for the manufacture of unsaturated fatty acid alkyl esters or glycerides having a total content of C 18:1 of about 30 to about 80 Mol-% by partial hydrogenation of unsaturated fatty acid esters having a total content of (C18:2+C18:3) of at least 65 Mol-%—calculated on the total amount of C18 moieties in the ester—which is characterised in that the hydrogenation is conducted in an aqueous/organic two phase system in the presence of a water soluble catalyst consisting of a Group VIII metal and a hydrophilic ligand. | 01-28-2010 |
| 20100234625 | Process for the Manufacture of Saturated Fatty Acid Esters - Disclosed is a process for the manufacture of saturated fatty acid esters by subjecting unsaturated fatty acid esters to hydrogenation in the presence of a catalyst suitable for catalysing the saturation of double bonds in the esters, which is characterised in that said catalyst represents a homogenous complex of a Group VIII metal and a sulfonated phosphite as the polar ionic ligand. | 09-16-2010 |
Achilleas Gravanis, Heraklion GR
| Patent application number | Description | Published |
|---|---|---|
| 20100234335 | NEUROSTEROID COMPOUNDS - The present invention relates to novel neurosteroid derivatives with anti-apoptotic, neuroprotective and neurogenic properties that act on the nervous system as well as methods for making the same and their applications in the treatment and/or prevention or amelioration of neurodegenerative diseases related to neuronal apoptosis or neuronal injury, or conditions related to or resulting from apoptosis, including but not limited to Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis and amyotrophic lateral sclerosis (ALS), retinal degeneration and detachment, peripheral neuropathy caused by genetic abnormalities, diabetes, polio, herpes, AIDS and chemotherapy, brain trauma, or ischemia and stroke. The active compounds are represented by Formula (I): wherein R | 09-16-2010 |
Achilleas Papakostas, Dallas, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20110053513 | METHODS AND APPARATUS TO IDENTIFY WIRELESS CARRIER PERFORMANCE EFFECTS - Example methods and apparatus to identify wireless carrier performance effects are disclosed. A disclosed example method includes receiving an indication of media content presentation on a wireless communication device, monitoring a wireless carrier operating parameter in response to receiving the indication of media content presentation, and monitoring the wireless communication device for a media content presentation command. The example method also includes associating the media content presentation command and the wireless carrier operating parameter with a scoring factor indicative of subscriber preferences, and generating a report including the scoring factor. | 03-03-2011 |
| 20120005213 | METHODS AND APPARATUS TO OBTAIN ANONYMOUS AUDIENCE MEASUREMENT DATA FROM NETWORK SERVER DATA FOR PARTICULAR DEMOGRAPHIC AND USAGE PROFILES - Methods and apparatus to obtain anonymous audience measurement data from network server data for particular demographic and usage profiles are disclosed. An example method to provide anonymous audience measurement data to an audience measurement entity disclosed herein comprises obtaining a demographic profile and a network usage profile, sampling customer data stored in a customer database not accessible by the audience measurement entity to generate a customer sample representative of the demographic profile and the network usage profile without customer intervention, the customer sample including customer identification information, processing log data obtained from a network server not accessible by the audience measurement entity using the customer identification information to determine audience measurement data associated with customers in the customer sample, and removing the customer identification information from the audience measurement data to prepare the anonymous audience measurement data for the audience measurement entity. | 01-05-2012 |
Achilleas Papakostas, Richardson, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120042005 | SYSTEMS, METHODS, AND APPARATUS TO MONITOR MOBILE INTERNET ACTIVITY - Systems, methods, and apparatus to monitor mobile Internet activity are disclosed. An example method comprises receiving a request for Internet content on a port of a proxy, the request originating from a mobile device transmitting requests via a cellular wireless access point; associating the request for Internet content with a mobile device based on the first port; requesting content from an Internet content provider identified in the request for Internet content, the Internet content provider being different than the proxy; and transmitting the content. | 02-16-2012 |
| 20120042367 | SYSTEMS, METHODS, AND APPARATUS TO MONITOR MOBILE INTERNET ACTIVITY - Systems, methods, and apparatus to monitor mobile Internet activity are disclosed. An example method comprises determining if an application identified by an identifier of a content request from a client device supports authentication; transmitting content identified by the content request to the client device if the identifier of the content request identifies an application that supports authentication; and storing an identifier of the content requested by the content request in association with the client device. | 02-16-2012 |
Achilleas Tsortos, Heraklion GR
| Patent application number | Description | Published |
|---|---|---|
| 20110048114 | MOLECULAR CONFORMATION BIOSENSING - Disclosed is a method of investigating the conformation of biomolecules or changes in the conformation of biomolecules as a result of an interaction, in which biomolecules from a sample of biomolecules are adhered discretely to the sensing surface of an acoustic wave sensor operating in a liquid, and a conformation parameter which is related to the conformation of the biomolecules from the said sample which are adhered discretely to the sensing surface, but substantially independent of the resulting change in mass loading of the sensing surface, is calculated from the resulting change in the output signals of the acoustic wave sensor. The conformation parameter may the acoustic ratio or a parameter which is directly related to the acoustic ratio. There is also disclosed a method of investigating changes in the conformation of biomolecules which are adhered discretely to the sensing surface of an acoustic wave sensor operating in a liquid, in response to an interaction with an agent, by calculating a conformation parameter which is related to the change in conformation of biomolecules adhered discretely to the sensing surface as a result of an interaction with the agent, but which is substantially independent of any resulting change in mass loading of the sensing surface. | 03-03-2011 |
Achilleas Tsoukalis, Anavyssos (attiki) GR
| Patent application number | Description | Published |
|---|---|---|
| 20100228110 | IMPLANTABLE BIOSENSOR WITH AUTOMATIC CALIBRATION - Implantable self-calibrating biosensor Subcutaneously or intracorporeally implantable biosensor, characterized by a closed microfluidic circuit with calibrating fluids, which communicates by a backward micro-dialysis logic with the exterior of said circuit, an open and in contact with the tissues and the interstitial fluid working electrode, for its self-calibration. One or more working electrodes may be positioned inside openable boxes from EAP, and be opened for the duration of the measurement and closed immediately after, succeeding one another in the measurement, as their sensitivity is diminished. | 09-09-2010 |
| 20110009814 | INFUSION PUMP - Described is an infusion pump comprising electronic infusion regulating means with wired or wireless communication means and a power source, a medicament bag ( | 01-13-2011 |
Achilleas Tsoukalis, Pallini GR
| Patent application number | Description | Published |
|---|---|---|
| 20120016295 | PUMP INFUSION SYSTEM - In a pump infusion system comprising a pump adapted to be attached to a user and to cause infusion of pharmaceutical substances into the user's body, questions regarding the effects of administration of the pharmaceutical substances are provided, answers to said questions are transmitted to an attending staff, said answers are recorded, and said pump is controlled so as to adjust the dose of the pharmaceutical substances in accordance with said answers. Further, for a safe remote programming of such a pump infusion system, a predetermined program is assigned, a protocol to be programmed is compared with a protocol coming from the pump, possible errors of non-medically certified intervening devices and means are eliminated, and the programming is executed. | 01-19-2012 |